Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › RACELAND › OCHSNER BAYOU LLC

OCHSNER BAYOU LLC

NPI: 1396761805 · RACELAND, LA 70394 · Psychiatric Hospital Unit · NPI assigned 07/15/2006

$29.19M
Total Medicaid Paid
557,888
Total Claims
481,841
Beneficiaries
192
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLEBLANC, FERNIS (CEO)
NPI Enumeration Date07/15/2006

Related Entities

Other providers sharing the same authorized official: LEBLANC, FERNIS

ProviderCityStateTotal Paid
OCHSNER MORGAN CITY LLC MORGAN CITY LA $10.29M
OCHSNER BAYOU, LLC RACELAND LA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 70,044 $2.48M
2019 74,661 $3.56M
2020 64,169 $3.30M
2021 78,589 $4.65M
2022 98,954 $5.30M
2023 101,634 $5.77M
2024 69,837 $4.13M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 35,390 32,172 $9.30M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 14,056 12,622 $3.51M
99283 Emergency department visit for the evaluation and management, moderate severity 20,824 19,307 $3.36M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 60,717 52,977 $2.07M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 17,395 15,840 $1.11M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 20,940 17,637 $817K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 17,164 15,578 $679K
70450 Computed tomography, head or brain; without contrast material 3,384 3,030 $667K
71045 Radiologic examination, chest; single view 8,142 7,376 $555K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 11,085 9,934 $431K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,079 979 $419K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,632 6,468 $348K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 11,196 7,991 $340K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 10,268 9,463 $311K
74176 Computed tomography, abdomen and pelvis; without contrast material 928 833 $296K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 9,962 8,857 $276K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,550 2,374 $261K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5,340 4,370 $248K
80053 Comprehensive metabolic panel 30,634 26,599 $236K
71046 Radiologic examination, chest; 2 views 3,116 2,907 $222K
81514 1,154 995 $220K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 487 211 $182K
96361 Intravenous infusion, hydration; each additional hour 5,897 4,454 $181K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 30,056 26,072 $172K
96375 Therapeutic injection; each additional sequential IV push 4,049 3,209 $161K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,506 1,951 $157K
74019 1,495 1,351 $134K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,607 2,115 $130K
83880 5,266 4,709 $126K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,730 1,505 $115K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,637 3,238 $110K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,650 3,236 $108K
36415 Collection of venous blood by venipuncture 45,030 37,738 $106K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 472 371 $97K
81025 12,147 10,880 $85K
84484 10,170 7,599 $78K
87634 1,147 1,051 $72K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,084 903 $69K
20610 236 194 $53K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,949 1,462 $52K
72100 751 689 $51K
87481 771 684 $50K
73564 530 493 $47K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 718 681 $45K
73630 562 507 $44K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,931 2,696 $41K
83690 7,484 6,713 $40K
82553 5,234 3,881 $40K
J0561 Injection, penicillin g benzathine, 100,000 units 270 224 $40K
73130 452 415 $38K
84443 Thyroid stimulating hormone (TSH) 3,119 2,717 $35K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1,631 1,473 $34K
81000 11,227 9,921 $31K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,930 2,643 $28K
80050 General health panel 769 700 $28K
82550 6,571 5,053 $28K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,294 1,128 $27K
59025 Fetal non-stress test 258 172 $26K
87040 3,664 1,951 $25K
87400 1,748 816 $25K
J1885 Injection, ketorolac tromethamine, per 15 mg 6,588 5,921 $25K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 669 594 $22K
87086 Culture, bacterial; quantitative colony count, urine 3,554 3,182 $22K
73560 311 290 $22K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 43 43 $22K
80061 Lipid panel 1,962 1,814 $20K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 776 684 $19K
87081 2,749 2,566 $19K
83605 2,550 2,054 $19K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,041 5,291 $15K
73610 195 180 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 799 659 $15K
85379 2,031 1,845 $15K
81003 8,773 7,527 $14K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,638 2,420 $14K
73562 191 179 $13K
J2360 Injection, orphenadrine citrate, up to 60 mg 720 655 $13K
73030 181 167 $12K
87807 908 834 $12K
80179 902 802 $11K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 513 469 $11K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 261 229 $10K
83036 Hemoglobin; glycosylated (A1C) 1,246 1,146 $10K
87660 447 377 $9K
87510 432 365 $8K
87480 432 365 $8K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 955 914 $8K
72040 141 124 $8K
82607 769 633 $8K
82746 764 628 $8K
83735 1,587 1,385 $7K
99215 Prolong outpt/office vis 129 125 $7K
85730 1,885 1,662 $7K
84439 1,087 913 $7K
77067 Screening mammography, bilateral, including computer-aided detection 66 66 $6K
84145 396 327 $6K
86803 448 413 $6K
J2270 Injection, morphine sulfate, up to 10 mg 1,993 1,729 $6K
71275 Computed tomographic angiography, chest, with contrast material 17 13 $5K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 198 172 $5K
85610 1,995 1,771 $5K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 60 54 $5K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 116 109 $5K
84100 1,450 1,272 $5K
0002A 144 128 $5K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 30 27 $4K
J1170 Injection, hydromorphone, up to 4 mg 941 786 $4K
76830 Ultrasound, transvaginal 41 39 $4K
86703 345 293 $4K
90686 335 299 $4K
84702 273 212 $4K
87186 714 592 $3K
0001A 135 131 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 194 164 $3K
87077 699 577 $3K
87088 519 459 $3K
84481 379 290 $3K
J1030 Injection, methylprednisolone acetate, 40 mg 296 270 $3K
80320 408 303 $3K
59430 19 13 $3K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 627 467 $2K
72125 Computed tomography, cervical spine; without contrast material 14 13 $2K
90715 90 82 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 26 25 $2K
85027 402 341 $2K
80329 288 230 $2K
96160 114 94 $2K
84425 147 118 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 13 12 $2K
J7030 Infusion, normal saline solution , 1000 cc 519 360 $2K
80048 Basic metabolic panel (calcium, ionized) 211 192 $1K
72170 39 38 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg 304 209 $1K
76801 12 12 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 15 14 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg 507 441 $1K
74018 12 12 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 496 452 $1K
82962 324 262 $1K
77063 Screening digital breast tomosynthesis, bilateral 66 65 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 27 24 $916.27
80055 37 37 $878.02
86593 243 211 $864.66
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 13 12 $864.00
85007 341 286 $839.80
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 145 137 $830.01
J2060 Injection, lorazepam, 2 mg 312 266 $826.58
87653 26 25 $820.05
94760 127 105 $816.03
82728 87 76 $788.96
96376 54 41 $743.85
0071A 18 17 $688.17
J2550 Injection, promethazine hcl, up to 50 mg 391 334 $638.80
J2175 Injection, meperidine hydrochloride, per 100 mg 200 182 $603.49
86850 143 119 $574.03
83655 46 45 $549.05
86140 143 125 $520.11
85651 181 159 $506.61
0072A 13 13 $498.94
J3490 Unclassified drugs 92 55 $464.77
87147 66 50 $405.66
J7120 Ringers lactate infusion, up to 1000 cc 100 95 $325.15
83615 72 66 $324.68
84144 15 13 $310.11
82950 70 66 $284.15
86901 128 105 $278.63
86900 128 105 $278.62
84466 26 26 $271.16
87340 30 25 $244.48
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 24 14 $220.51
86308 48 38 $217.93
86762 12 12 $174.85
90656 44 34 $158.25
J1040 Injection, methylprednisolone acetate, 80 mg 12 12 $142.29
83540 26 26 $137.47
81002 37 37 $123.21
99459 197 160 $113.36
0352U 112 93 $89.50
J2003 Injection, lidocaine hydrochloride, 1 mg 43 31 $79.96
82803 12 12 $57.92
81001 13 12 $56.11
82043 12 12 $46.77
82570 12 12 $41.90
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 12 12 $41.83
91300 329 277 $5.62
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3,469 2,489 $0.00
G0008 Administration of influenza virus vaccine 17 17 $0.00
99309 Subsequent nursing facility care, per day, low to moderate complexity 77 32 $0.00
91307 45 42 $0.00
99308 Subsequent nursing facility care, per day, straightforward 40 21 $0.00
99490 Ccm add 20min 660 328 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 210 193 $0.00